Ben Taylor has served as President and Chief Financial Officer of Tyme Inc. since 2017. Ben brings decades of experience in investment banking and emerging growth companies. From 2016 to 2017, Ben was Head of Commercial Pharma for Barclays Capital Inc. Prior to Barclays, Ben spent ten years at Goldman, Sachs & Co., where he held a variety of roles, including Head of Emerging Pharma and Co-Head of Chinese and Southeast Asian Healthcare within the investment banking division. His career has primarily been focused on biopharmaceuticals, working as an advisor to over a hundred companies at various stages of development in more than 15 countries.

On this episode, Ben discusses:

- Why he left a high profile and secure position on Wall Street to join Tyme's executive team

- An inside look at what goes into the development of a drug from a business perspective

- Tyme's partnership with PanCAN

- Day to day life as the President and CFO of an emerging biotech company